International Meeting for Autism Research (May 7 - 9, 2009): Association Study of Neurexin 1 and Neuroligin 3 & 4 Genes with French Autistic Patients

Association Study of Neurexin 1 and Neuroligin 3 & 4 Genes with French Autistic Patients

Friday, May 8, 2009
Northwest Hall (Chicago Hilton)
11:00 AM
F. Laaghouiti , U675 Inserm, INSERM, Paris, France
P. Gorwood , U675 Inserm, INSERM, Paris, France
B. Golse , Service de Psychiatrie de l'Enfant et de l'Adolescent, AP-HP, Paris, France
L. Robel , Service de Psychiatrie de l'Enfant et de l'Adolescent, AP-HP, Paris, France
N. Ramoz , U675 Inserm, INSERM, Paris, France
Background: Beta-neurexin and neuroligin molecules form an intercellular adhesion complex sufficient to trigger formation of functional presynaptic elements. Mutations and copy number variants have been identified in neurexin 1 (NRXN1) and neuroligins 3 & 4 (NLGN3 & NLGN4) genes in autistic patients.

Objectives: Our goal is to identify association between autism and polymorphisms of NRXN1, NLGN3 and NLGN4 genes.

Methods: We performed a case-control study by genotyping 9 single nucleotide polymorphisms (SNPs) within NRXN1, NLGN3 and NLGN4 genes, using TaqMan® SNP Genotyping Assays, on 84 French autistic patients, 26 parents, and 143 healthy controls matching for the geographic origin. Distributions of alleles and genotypes were compared between patients and controls. Transmission disequilibrium test was carried out in families.

Results: SNPs were on Hardy-Weinberg equilibrium. No significant differences of frequency for alleles or genotypes were found between autistic patients and controls. In particular, no variation was observed for the missense mutation R451C in the NLGN3 gene. No excess of transmission was showed from parents to patients.

Conclusions: No association between polymorphisms in NRXN1, NLGN3 and NLGN4 genes was identified with autism in this study.

See more of: Poster III
See more of: Poster Presentations